Reihl Oliver, Biemel Klaus M, Eipper Wolfgang, Lederer Markus O, Schwack Wolfgang
Institute of Food Chemistry, University of Hohenheim, Garbenstrasse 28, D-70593 Stuttgart, Germany.
J Agric Food Chem. 2003 Jul 30;51(16):4810-8. doi: 10.1021/jf034292+.
Covalently cross-linked proteins are among the major modifications caused by the advanced Maillard reaction. So far, the chemical nature of these aggregates is largely unknown. Investigations are reported on the isolation of 6-[2-[[(4S)-4-amino-4-carboxybutyl]amino]-6,7-dihydroxy-6,7-dihydroimidazo[4,5-b]azepin-4(5H)-yl]-L-norleucine (10) and N-acetyl-6-[(6R,7R)-2-[[4-(acetylamino)-4-carboxybutyl]amino]-6,7,8a-trihydroxy-6,7,8,8a-tetrahydroimidazo[4,5-b]azepin-4(5H)-yl]-L-norleucine (12) formed by oxidation of the major Maillard cross-link glucosepane 1. Independent synthesis and unequivocal structural characterization are given for 10 and 12. Spiro cross-links, representing a new class of glycoxidation products, were obtained by dehydrogenation of the amino imidazolinimine compounds N6-[2-[[(4S)-4-ammonio-5-oxido-5-oxopentyl]amino]-5-[(2S,3R)-2,3,4-trihydroxybutyl]-3,5-dihydro-4H-imidazol-4-ylidene]-L-lysinate (DOGDIC 2) and N6-[2-[[(4S)-4-ammonio-5-oxido-5-oxopentyl]amino]-5-[(2S)-2,3-dihydroxypropyl]-3,5-dihydro-4H-imidazol-4-ylidene]-L-lysinate (DOPDIC 3). These new oxidation products were synthesized, and their unambiguous structural elucidation proved the formation of the spiro imidazolimine structures N6-[(7R,8S)-2-[[(4S)-4-ammonio-5-oxido-5-oxopentyl]amino]-8-hydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.4]non-1-en-4-ylidene]-L-lysinate (16), N6-(8R,9S)-2-[(4S)-4-ammonio-5-oxido-5-oxopentyl]amino]-8,9-dihydroxy-6-oxa-1,3-diazaspiro[4.5]dec-1-en-4-ylidene)-L-lysinate (19), and N6-[(8S)-2-[(4-amino-4-carboxybutyl)amino]-8-hydroxy-6-oxa-1,3-diazaspiro[4.4]non-1-en-4-ylidene]-L-lysinate (18), respectively. It was shown that reaction of the imidazolinone 15 led to the formation of spiro imidazolones, structurally analogous to 16 and 19.
共价交联蛋白是晚期美拉德反应引起的主要修饰产物之一。到目前为止,这些聚集体的化学性质在很大程度上还不清楚。本文报道了对6-[2-[[(4S)-4-氨基-4-羧基丁基]氨基]-6,7-二羟基-6,7-二氢咪唑并[4,5-b]氮杂环庚烷-4(5H)-基]-L-正亮氨酸(10)和N-乙酰基-6-[(6R,7R)-2-[[4-(乙酰氨基)-4-羧基丁基]氨基]-6,7,8a-三羟基-6,7,8,8a-四氢咪唑并[4,5-b]氮杂环庚烷-4(5H)-基]-L-正亮氨酸(12)的分离研究,它们是由主要的美拉德交联物葡糖盘尼西林1氧化形成的。给出了10和12的独立合成及明确的结构表征。通过对氨基咪唑啉亚胺化合物N6-[2-[[(4S)-4-铵基-5-氧化-5-氧代戊基]氨基]-5-[(2S,3R)-2,3,4-三羟基丁基]-3,5-二氢-4H-咪唑-4-亚基]-L-赖氨酸盐(DOGDIC 2)和N6-[2-[[(4S)-4-铵基-5-氧化-5-氧代戊基]氨基]-5-[(2S)-2,3-二羟基丙基]-3,5-二氢-4H-咪唑-4-亚基]-L-赖氨酸盐(DOPDIC 3)进行脱氢反应,得到了代表一类新型糖氧化产物的螺交联物。合成了这些新的氧化产物,其明确的结构解析证明分别形成了螺咪唑啉亚胺结构N6-[(7R,8S)-2-[[(4S)-4-铵基-5-氧化-5-氧代戊基]氨基]-8-羟基-